Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06986954 · ClinicalTrials.gov registry record

Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

A clinical trial of Stroke and Stenosis, sponsored by Cook Research Incorporated.

Recruiting
Registry status
588
Enrollment target
1
Study location

NCT06986954: Recruiting study of Stroke and Stenosis, sponsored by Cook Research Incorporated.

NCT06986954 is a study of Stroke and Stenosis that is actively recruiting participants, run by Cook Research Incorporated. The registered enrollment target is 588 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06986954, a study of Stroke and Stenosis, is actively recruiting participants, sponsored by Cook Research Incorporated.

RECRUITING
Registry status
588 participants
Enrollment target
1
Study location

Study Summary

This prospective observational post-market clinical study will collect data in the United States to primarily support the re-launch of the re-designed Beacon Tip Sizing Catheter and Slip-Catheter Beacon Tip Catheter \& Shuttle Select Slip-Catheter (Visceral and Cerbral) for a Conformité Européenne (CE) Mark application in the European Union (EU). Additionally, the data from this study may be used to support regulatory approval in other countries/regions. The purpose of this clinical study is to evaluate the safety and performance of these catheters in accordance with the Intended Use through the end of index procedure, and through 30 days post procedure, (as applicable as data is available) to ensure an acceptable benefit:risk ratio.

Primary Outcome

The primary performance outcome is successful navigation to the intended location The percent of successful navigation to the intended location

Conditions Studied

Stroke Stenosis TIA Pseudoaneurysm Vascular Malformation Bleed Intracranial

Interventions

  • DEVICE Beacon Tip Catheters

Study Locations (1)

Connecticut

  • Vascular Breakthroughs - Darien

Trial Details

FieldValue
Enrollment Target 588 participants
Start Date 2025-04-20
Est. Completion 2026-07-31
Cook Research Incorporated

24 total trials

What NCT06986954 shows while recruiting

NCT06986954 is an observational study that tracks outcomes without assigning an intervention. The registered 588 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower).

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Beacon Tip Catheters is the first listed.

NCT06986954 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT06986954 about?

NCT06986954 is a clinical study titled "Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study". This prospective observational post-market clinical study will collect data in the United States to primarily support the re-launch of the re-designed Beacon Tip Sizing Catheter and Slip-Catheter Beacon Tip Catheter \& Shuttle Select Slip-Catheter (Visceral and Cerbral) for a Conformité Européenne (...

What is the current status of trial NCT06986954?

This trial is currently recruiting. The enrollment target is 588 participants. The study started on 2025-04-20. Estimated completion is 2026-07-31.

What conditions does trial NCT06986954 study?

This clinical trial studies the following conditions: Stroke, Stenosis, TIA, Pseudoaneurysm, Vascular Malformation.

What interventions are being tested in trial NCT06986954?

The interventions under investigation include: Beacon Tip Catheters (DEVICE).

Who is sponsoring clinical trial NCT06986954?

This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06986954 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06986954's enrollment target sits among peer trials

588 51st of 454 higher than 404 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06921603 · 588 participants · NA

    POCUS-Guided Diuresis for Decompensated Heart Failure

  • NCT01365169 · 590 participants · NA

    Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

  • NCT03774758 · 590 participants

    Biomarkers for Risk Stratification in Lung Cancer

  • NCT04747626 · 590 participants · NA

    B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06986954

Source: ClinicalTrials.gov NCT06986954, the US trial registry maintained by the National Library of Medicine. NCT06986954 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.